NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.27 +0.58 (3.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.69 | 52 Week High | $9.54 | |||
| Open | $16.91 | 52 Week Low | $5.49 | |||
| Day High | $17.48 | P/E | 431.75 | |||
| Day Low | $16.69 | EPS | $0.04 | |||
| Volume | 2,753,348 | |||||
